Whitepaper

Remdesivir In COVID-19
The leading COVID-19 antiviral drug - Remdesivir - proving its value in the treatment of severe as well as moderately affected patients
REMDESIVIR IN COVID-19

More Whitepapers / Newsletters

Induced Pluripotent Stem Cells (IPSCs) Research And Development
Induced Pluripotent Stem Cells...

IPSCs have enormous applications in the field of regenerative medicine, disease modelling, and drug discovery. For the development of regenerative medicine, somatic cells from a diseased patient are u...

Pompe Disease Newsletter
Pompe Disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also c...

Cancer In The United States(Vol 1, Issue 2)
Cancer In The United States(Vo...

US Cancer Statistics show that more than half a million suffer from this disease, which is the second leading cause of death in the country. The newsletter Cancer in the US substantiates the increasin...

Fibrodysplasia Ossificans Progressiva Newsletter
Fibrodysplasia Ossificans Prog...

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification of the connective tissues and muscle tissues, such as ligaments and tendons. They are replaced by bo...

Retinitis Pigmentosa
Retinitis Pigmentosa

Retinitis pigmentosa is a gradual deterioration of the ability of eyes to see. The defect in the eye is inflicted upon the light-sensitive tissue – the retina, which is the leading cause of blindness....